Dublin, Nov. 22, 2013 (GLOBE NEWSWIRE) -- Research and Markets
(http://www.researchandmarkets.com/research/3wllkk/cns_therapeutics)
has announced the addition of the
"CNS Therapeutics - Global Strategic Business Report" report to
their offering.
This report analyzes the worldwide markets for
CNS Therapeutics in US$ Million by the following Product
Groups: Anti-Alzheimers, Anti-Parkinsons, Anti-Epilepsy, Pain
Management (includes Migraine, Nociceptive and neuropathic pain),
Anti-Psychotics, Anti-Depressants, and Others (includes Multiple
Sclerosis, Insomnia and ADHD). The report provides separate
comprehensive analytics for the US, Canada, Europe, Asia-Pacific,
Latin America, and Rest of World. Annual estimates and forecasts
are provided for the period 2010 through 2018.
The report profiles 127 companies including many key and niche
players such as AbbVie Inc., Alkermes Plc, Amneal Pharmaceuticals,
LLC, Aspen Pharmacare Holdings Limited, AstraZeneca Plc, BEACON
Pharmaceutical Limited, BIAL Group, Boehringer Ingelheim GmbH,
Bristol-Myers Squibb, Dainippon Sumitomo Pharma Co., Ltd., Eisai
Co., Ltd., Elan Corporation Plc, Eli Lilly and Co., F. Hoffmann-La
Roche Ltd., Fabre-Kramer Pharmaceuticals, Inc., Forest
Laboratories, Inc., GlaxoSmithKline, H. Lundbeck A/S, Johnson &
Johnson, Janssen Pharmaceuticals, Inc., Merck & Co., Inc.,
Neurocrine Biosciences, Inc., Novartis AG, Otsuka Pharmaceutical
Co., Ltd., Pfizer, Inc., Sanofi S.A, Shire Plc, Sunovion
Pharmaceuticals, Inc., Takeda Pharmaceutical Co., Ltd., Teva
Pharmaceutical Industries Ltd., and UCB Group.
Key Topics Covered:
I. INTRODUCTION, METHODOLOGY & PRODUCT DEFINITIONS
II. Executive Summary
1. INDUSTRY OVERVIEW
2. MARKET OVERVIEW & TRENDS ACROSS CNS THERAPEUTIC AREAS
3. CHANGING HEALTHCARE INDUSTRY IN EUROPE & THE UNITED
STATES
4. PRODUCT OVERVIEW
5. REVIEW OF SELECT CNS DRUGS
6. RESEARCH & DEVELOPMENT
7. PRODUCT INTRODUCTIONS/INNOVATIONS
8. RECENT INDUSTRY ACTIVITY
9. FOCUS ON SELECT GLOBAL PLAYERS
10. GLOBAL MARKET PERSPECTIVE
III. MARKET
1. THE UNITED STATES
2. CANADA
3. EUROPE
4. ASIA-PACIFIC
5. LATIN AMERICA
6. REST OF WORLD
IV. COMPETITIVE LANDSCAPE
Total Companies Profiled: 127 (including Divisions/Subsidiaries -
157)
- The United States (60)
- Canada (11)
- Japan (10)
- Europe (61)
- - France (4)
- - Germany (10)
- - The United Kingdom (10)
- - Italy (1)
- - Spain (1)
- - Rest of Europe (35)
- Asia-Pacific (Excluding Japan) (8)
- Middle-East (6)
- Africa (1)
For more information visit http://www.researchandmarkets.com/research/3wllkk/cns_therapeutics
Research and Markets
Laura Wood, Senior Manager.
press@researchandmarkets.com
U.S. Fax: 646-607-1907
Fax (outside U.S.): +353-1-481-1716
Sector:
Pharmaceuticals